Global Digital Therapeutics for Endocrine System Diseases Market Growth (Status and Outlook) 2026-2032

May 2026 | 77 pages | ID: G50DA5AA7DD2EN
LP Information

Abstracts

The global Digital Therapeutics for Endocrine System Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Digital Therapeutics for Endocrine System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent endocrine system diseases.

United States market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Digital Therapeutics for Endocrine System Diseases players cover Livongo, SHANGYI, EnteroMedics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Digital Therapeutics for Endocrine System Diseases Industry Forecast” looks at past sales and reviews total world Digital Therapeutics for Endocrine System Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Digital Therapeutics for Endocrine System Diseases sales for 2026 through 2032. With Digital Therapeutics for Endocrine System Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Therapeutics for Endocrine System Diseases industry.

This Insight Report provides a comprehensive analysis of the global Digital Therapeutics for Endocrine System Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Therapeutics for Endocrine System Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Therapeutics for Endocrine System Diseases market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Therapeutics for Endocrine System Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Therapeutics for Endocrine System Diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital Therapeutics for Endocrine System Diseases market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Prevention
• Management
• Treatment

Segmentation by Application:

• Diabetes
• Metabolic Syndrome
• Obesity
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Livongo
• SHANGYI
• EnteroMedics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Digital Therapeutics for Endocrine System Diseases Market Size (2021-2032)
  2.1.2 Digital Therapeutics for Endocrine System Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Digital Therapeutics for Endocrine System Diseases by Country/Region (2021, 2025 & 2032)
2.2 Digital Therapeutics for Endocrine System Diseases Segment by Type
  2.2.1 Prevention
  2.2.2 Management
  2.2.3 Treatment
  2.2.4 Digital Therapeutics for Endocrine System Diseases Market Size by Type
    2.2.4.1 Digital Therapeutics for Endocrine System Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2021-2026)
2.3 Digital Therapeutics for Endocrine System Diseases Segment by Application
  2.3.1 Diabetes
  2.3.2 Metabolic Syndrome
  2.3.3 Obesity
  2.3.4 Other
  2.3.5 Digital Therapeutics for Endocrine System Diseases Market Size by Application
    2.3.5.1 Digital Therapeutics for Endocrine System Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.5.2 Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application (2021-2026)

3 DIGITAL THERAPEUTICS FOR ENDOCRINE SYSTEM DISEASES MARKET SIZE BY PLAYER

3.1 Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Player
  3.1.1 Global Digital Therapeutics for Endocrine System Diseases Revenue by Player (2021-2026)
  3.1.2 Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Digital Therapeutics for Endocrine System Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DIGITAL THERAPEUTICS FOR ENDOCRINE SYSTEM DISEASES BY REGION

4.1 Digital Therapeutics for Endocrine System Diseases Market Size by Region (2021-2026)
4.2 Global Digital Therapeutics for Endocrine System Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Digital Therapeutics for Endocrine System Diseases Market Size Growth (2021-2026)
4.4 APAC Digital Therapeutics for Endocrine System Diseases Market Size Growth (2021-2026)
4.5 Europe Digital Therapeutics for Endocrine System Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Digital Therapeutics for Endocrine System Diseases Market Size by Country (2021-2026)
5.2 Americas Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026)
5.3 Americas Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Digital Therapeutics for Endocrine System Diseases Market Size by Region (2021-2026)
6.2 APAC Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026)
6.3 APAC Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2021-2026)
7.2 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026)
7.3 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Digital Therapeutics for Endocrine System Diseases by Region (2021-2026)
8.2 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DIGITAL THERAPEUTICS FOR ENDOCRINE SYSTEM DISEASES MARKET FORECAST

10.1 Global Digital Therapeutics for Endocrine System Diseases Forecast by Region (2027-2032)
  10.1.1 Global Digital Therapeutics for Endocrine System Diseases Forecast by Region (2027-2032)
  10.1.2 Americas Digital Therapeutics for Endocrine System Diseases Forecast
  10.1.3 APAC Digital Therapeutics for Endocrine System Diseases Forecast
  10.1.4 Europe Digital Therapeutics for Endocrine System Diseases Forecast
  10.1.5 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Forecast
10.2 Americas Digital Therapeutics for Endocrine System Diseases Forecast by Country (2027-2032)
  10.2.1 United States Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.2.2 Canada Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.2.3 Mexico Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.2.4 Brazil Market Digital Therapeutics for Endocrine System Diseases Forecast
10.3 APAC Digital Therapeutics for Endocrine System Diseases Forecast by Region (2027-2032)
  10.3.1 China Digital Therapeutics for Endocrine System Diseases Market Forecast
  10.3.2 Japan Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.3.3 Korea Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.3.4 Southeast Asia Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.3.5 India Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.3.6 Australia Market Digital Therapeutics for Endocrine System Diseases Forecast
10.4 Europe Digital Therapeutics for Endocrine System Diseases Forecast by Country (2027-2032)
  10.4.1 Germany Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.4.2 France Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.4.3 UK Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.4.4 Italy Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.4.5 Russia Market Digital Therapeutics for Endocrine System Diseases Forecast
10.5 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Forecast by Region (2027-2032)
  10.5.1 Egypt Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.5.2 South Africa Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.5.3 Israel Market Digital Therapeutics for Endocrine System Diseases Forecast
  10.5.4 Turkey Market Digital Therapeutics for Endocrine System Diseases Forecast
10.6 Global Digital Therapeutics for Endocrine System Diseases Forecast by Type (2027-2032)
10.7 Global Digital Therapeutics for Endocrine System Diseases Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Digital Therapeutics for Endocrine System Diseases Forecast

11 KEY PLAYERS ANALYSIS

11.1 Livongo
  11.1.1 Livongo Company Information
  11.1.2 Livongo Digital Therapeutics for Endocrine System Diseases Product Offered
  11.1.3 Livongo Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Livongo Main Business Overview
  11.1.5 Livongo Latest Developments
11.2 SHANGYI
  11.2.1 SHANGYI Company Information
  11.2.2 SHANGYI Digital Therapeutics for Endocrine System Diseases Product Offered
  11.2.3 SHANGYI Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 SHANGYI Main Business Overview
  11.2.5 SHANGYI Latest Developments
11.3 EnteroMedics
  11.3.1 EnteroMedics Company Information
  11.3.2 EnteroMedics Digital Therapeutics for Endocrine System Diseases Product Offered
  11.3.3 EnteroMedics Digital Therapeutics for Endocrine System Diseases Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 EnteroMedics Main Business Overview
  11.3.5 EnteroMedics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Digital Therapeutics for Endocrine System Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Digital Therapeutics for Endocrine System Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prevention
Table 4. Major Players of Management
Table 5. Major Players of Treatment
Table 6. Digital Therapeutics for Endocrine System Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2021-2026)
Table 9. Digital Therapeutics for Endocrine System Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global Digital Therapeutics for Endocrine System Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Player (2021-2026)
Table 14. Digital Therapeutics for Endocrine System Diseases Key Players Head office and Products Offered
Table 15. Digital Therapeutics for Endocrine System Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global Digital Therapeutics for Endocrine System Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Digital Therapeutics for Endocrine System Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC Digital Therapeutics for Endocrine System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Digital Therapeutics for Endocrine System Diseases
Table 40. Key Market Challenges & Risks of Digital Therapeutics for Endocrine System Diseases
Table 41. Key Industry Trends of Digital Therapeutics for Endocrine System Diseases
Table 42. Global Digital Therapeutics for Endocrine System Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Digital Therapeutics for Endocrine System Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Digital Therapeutics for Endocrine System Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Livongo Details, Company Type, Digital Therapeutics for Endocrine System Diseases Area Served and Its Competitors
Table 47. Livongo Digital Therapeutics for Endocrine System Diseases Product Offered
Table 48. Livongo Digital Therapeutics for Endocrine System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Livongo Main Business
Table 50. Livongo Latest Developments
Table 51. SHANGYI Details, Company Type, Digital Therapeutics for Endocrine System Diseases Area Served and Its Competitors
Table 52. SHANGYI Digital Therapeutics for Endocrine System Diseases Product Offered
Table 53. SHANGYI Digital Therapeutics for Endocrine System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. SHANGYI Main Business
Table 55. SHANGYI Latest Developments
Table 56. EnteroMedics Details, Company Type, Digital Therapeutics for Endocrine System Diseases Area Served and Its Competitors
Table 57. EnteroMedics Digital Therapeutics for Endocrine System Diseases Product Offered
Table 58. EnteroMedics Digital Therapeutics for Endocrine System Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. EnteroMedics Main Business
Table 60. EnteroMedics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Digital Therapeutics for Endocrine System Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Digital Therapeutics for Endocrine System Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Digital Therapeutics for Endocrine System Diseases Sales Market Share by Country/Region (2025)
Figure 8. Digital Therapeutics for Endocrine System Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type in 2025
Figure 10. Digital Therapeutics for Endocrine System Diseases in Diabetes
Figure 11. Global Digital Therapeutics for Endocrine System Diseases Market: Diabetes (2021-2026) & ($ millions)
Figure 12. Digital Therapeutics for Endocrine System Diseases in Metabolic Syndrome
Figure 13. Global Digital Therapeutics for Endocrine System Diseases Market: Metabolic Syndrome (2021-2026) & ($ millions)
Figure 14. Digital Therapeutics for Endocrine System Diseases in Obesity
Figure 15. Global Digital Therapeutics for Endocrine System Diseases Market: Obesity (2021-2026) & ($ millions)
Figure 16. Digital Therapeutics for Endocrine System Diseases in Other
Figure 17. Global Digital Therapeutics for Endocrine System Diseases Market: Other (2021-2026) & ($ millions)
Figure 18. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application in 2025
Figure 19. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Player in 2025
Figure 20. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Region (2021-2026)
Figure 21. Americas Digital Therapeutics for Endocrine System Diseases Market Size 2021-2026 ($ millions)
Figure 22. APAC Digital Therapeutics for Endocrine System Diseases Market Size 2021-2026 ($ millions)
Figure 23. Europe Digital Therapeutics for Endocrine System Diseases Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size 2021-2026 ($ millions)
Figure 25. Americas Digital Therapeutics for Endocrine System Diseases Value Market Share by Country in 2025
Figure 26. United States Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Region in 2025
Figure 31. APAC Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2021-2026)
Figure 32. APAC Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application (2021-2026)
Figure 33. China Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. India Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Country in 2025
Figure 40. Europe Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2021-2026)
Figure 41. Europe Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application (2021-2026)
Figure 42. Germany Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. France Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Digital Therapeutics for Endocrine System Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 56. APAC Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 57. Europe Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 59. United States Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 60. Canada Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 61. Mexico Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 62. Brazil Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 63. China Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 64. Japan Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 65. Korea Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 67. India Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 68. Australia Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 69. Germany Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 70. France Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 71. UK Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 72. Italy Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 73. Russia Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 74. Egypt Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 75. South Africa Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 76. Israel Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 77. Turkey Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)
Figure 78. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Digital Therapeutics for Endocrine System Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Digital Therapeutics for Endocrine System Diseases Market Size 2027-2032 ($ millions)